NFE2L2 and Hepatic fibrosis: The treatment method works by inhibiting the NLRP3-mediated anti-inflammatory activity and Nrf2-mediated antioxidant activity, leading to a reduction in liver angiogenesis and an overall improvement in hepatic fibrosis.